Global Pharmaceutical Analytical Testing Outsourcing Services Market Size

 decision foresight.png

Global Pharmaceutical Analytical Testing Outsourcing Services Market Size, Share, Growth, Industry Trends and Forecast 2020-2030


Analytical testing services help pharmaceutical companies in providing real-time product quality control along with optimizing and monitoring processes, characterizing biosimilars & biologics, and improving productivity. Developing advanced analytical testing to assess and monitor the quality attributes of these products requires a broader set of equipment and expertise, which is beyond the internal capacity of pharma companies. This has subsequently lead to an increase in the requirement of outsourcing pharmaceutical analytical testing services. One of the main reasons for outsourcing analytical testing services is to get benefited from skilled and experienced professionals, as well as to access expensive analytical equipment that is not available in-house. Increased development of biologics is also creating a demand for analytical testing services. In the last three decades, biologics have played an important role in the discovery and development of drugs. Increasing focus on customized services and technological advancements is shortening the product lifecycle, which has resulted in the rapid development of new products. Outsourcing services are the most favored option for many pharmaceutical companies to increase access therapeutic expertise, operational efficiency, and benefit from on-demand services. Global pharmaceutical analytical testing outsourcing services market accounted 6.6 USD billion in 2020 and is expected to reach 15.3 USD billion by 2030 growing with a CAGR of 8.7% during the forecast period.

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020133

Market Dynamics and Factors:

Increasing pipelines for biologic drugs, rising demand for additional analytical details on drugs, and process development by regulatory agencies are boosting the market growth. Technology transfer and services extension from one region to another, which requires Government approval may slow down the growth of the pharmaceutical analytical testing outsourcing services market. The intensifying pressure on pharmaceutical and biopharmaceutical organizations in rejuvenating their drug pipelines across R&D cost-cutting measures will boost the demand for analytical testing outsourcing services.

Market Segmentation : 

  • Global Pharmaceutical Analytical Testing Outsourcing Services Market – By Bioanalytical Testing

    • Clinical

    • Non-Clinical

  • Global Pharmaceutical Analytical Testing Outsourcing Services Market – By Method Development & Validation 

    • Extractable & Leachable

    • Impurity Method

    • Technical Consulting

    • Others

  • Global Pharmaceutical Analytical Testing Outsourcing Services Market – By Stability Testing

    • Drug Substance

    • Stability Indicating Method Validation

    • Accelerated Stability

    • Photostability

    • Others

  • Global Pharmaceutical Analytical Testing Outsourcing Services Market – By Geography

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • U.K.

      • France

      • Germany

      • Italy

      • Rest of Europe

    • Asia-Pacific

      • Japan

      • China

      • India

      • Australia

      • Rest of Asia Pacific

    • ROW

      • Latin America

      • Middle East

      • Africa

New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020133

Geographic Analysis:

North America has dominated the global pharmaceutical analytical testing outsourcing services market with a share of 54.2% during 2019.  North America is one of the top manufacturing hubs of highly reliable, complex, and high-end pharmaceuticals and the reason why outsourcing of clinical bioanalytical testing services has emerged as the largest segment in this region, with a share of around 79%. The extractable and leachable services segment is expected to witness a significant growth rate owing to an increasing number of vendors offering these services at competitive prices. Asia Pacific is projected to be the fastest-growing market as an opportunity for the existing key players of developed countries, who are focusing on expanding their presence in this region. Outsourcing services in this region are generally supported by delivery centers in Manila, China, and India.

Competitive Scenario:

Some of the key players operating in the pharmaceutical analytical testing outsourcing services market are Toxikon, Inc.; Intertek Group PLC; SGS SA; Eurofins Scientific; Boston Analytical; Pace Analytical Services, LLC; West Pharmaceutical Services, Inc.; Intertek Group Plc; Pharmaceutical Product Development, LLC; WuXi AppTec, Inc.; and Charles River Laboratories International, Inc. 

Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020133

How will this Market Intelligence Report Benefit You?

  1. The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.

  2. Exclusive insight into the key trends affecting the Global Pharmaceutical Analytical Testing Outsourcing Services industry, although key threats, opportunities and disruptive technologies that could shape the Global Pharmaceutical Analytical Testing Outsourcing Services Market supply and demand.

  3. The report tracks the leading market players that will shape and impact the Global Pharmaceutical Analytical Testing Outsourcing Services Market most.

  4. The data analysis present in the Global Pharmaceutical Analytical Testing Outsourcing Services Market report is based on the combination of both primary and secondary resources.

  5. The report helps you to understand the real effects of key market drivers or retainers on Global Pharmaceutical Analytical Testing Outsourcing Services Market business.

The 2021 Annual Global Pharmaceutical Analytical Testing Outsourcing Services Market offers:

  • 100+ charts exploring and analysing the Global Pharmaceutical Analytical Testing Outsourcing Services Market from critical angles including retail forecasts, consumer demand, production and more

  • 15+ profiles of top producing states, with highlights of market conditions and retail trends

  • Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand

  • Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Pharmaceutical Analytical Testing Outsourcing Services Market type

Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020133

About Us:

Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.

Contact:

Email: sales@decisionforesight.com

For Latest Update Follow Us:

https://www.facebook.com/Decision-Foresight-110793387201935

https://twitter.com/DecisionFs

https://www.linkedin.com/company/decision-foresight/

Comments

Post a Comment

Popular posts from this blog

Digital Pathology

Image
  Global Digital Pathology Market Size, Share, Growth, Industry Trends and Forecast 2020-2030 Global Digital Pathology Market accounted USD 721.7 million in 2020 and is anticipated to reach USD 2281.7469 million by 2030, at a CAGR of 12.2% during the forecast period. It is an innovation predominantly committed to minimize laboratory expenses, increase operational efficiency, improving treatment decisions and patient care, and improved overall productivity. This technique incorporates the management, acquisition, sharing and interpretation of pathology information — which include slides and data — in a digital environment. Digital slides are produced when glass slides are apprehended with a scanning device, to deliver a high-resolution digital image that can be observed on a computer screen or mobile device. Virtual microscopy is a part of the market which enables to practice converting glass slides into digital slides that can be viewed, managed, shared and analyzed on a computer m...
Read more

Global Teleradiology Market

Image
  Global Teleradiology Market Size, Share, Growth, Industry Trends and Forecast 2020-2030 The global teleradiology market was expected at USD 3320.2 million in 2020 and is expected to reach USD 17674.4 million by 2030 with a CAGR of 18.2% during the forecast period.Teleradiology is a branch of telemedicine that has medical images construed by a radiologist from one location to another for diagnostic and consulting purpose. This facilitates patient care by allowing radiologists in providing services by removing the distance barrier as well as taking care of patient without being physically present at the patients' venue. And also interpretations through non-invasive imaging techniques such as CT, MRI, ultrasound, and nuclear medicine studies and X-rays, and in help proper disease diagnosis and its treatment that is followed by its appropriate treatment. It allows storage of digital radiograph images through picture archiving and communication system (PACS) and radiology information...
Read more

Global Antisense And RNAi Therapeutics Market

Image
  Global Antisense And RNAi Therapeutics Market Size, Share, Growth, Industry Trends and Forecast 2020-2030 Antisense and RNAi therapeutics are therapeutic treatments having the potential to treat diseases such as chronic liver and cardiovascular diseases, and other rare diseases. Antisense RNAi was the largest technology segment in 2018 due to technological advancement in the healthcare sector. Antisense technology is a method that can stop protein production. Antisense technology can be used to design new therapeutics for certain new diseases. The principle behind is antisense nucleic acid sequence base pairs with complementary sense RNA strand and avoids from being translated into a protein. Based on the triggering of the RNA molecules this technology is segmented into siRNA and miRNA. Antisense and RNAi therapeutics services are applicable in the treatment of a wide range of diseases that target nucleic acid and affect the cell growth cycle. miRNA has the ability to restore gen...
Read more